Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DARE.
- DOI
- 10.1007/s40257-026-01030-5
- Published
- 2026 Jul
- Container
- American journal of clinical dermatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40257-026-01030-5,
title = {Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DARE.},
author = {Yosipovitch G and Gooderham MJ and Elmariah SB and Bonfanti G and Edwards RA and Gregoriou S and Biswas P and Myers DE and Alderfer J and Güler E and Koulias C},
year = {2026},
journal = {American journal of clinical dermatology},
doi = {10.1007/s40257-026-01030-5},
url = {https://doi.org/10.1007/s40257-026-01030-5}
}RIS
TY - JOUR TI - Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DARE. AU - Yosipovitch G AU - Gooderham MJ AU - Elmariah SB AU - Bonfanti G AU - Edwards RA AU - Gregoriou S AU - Biswas P AU - Myers DE AU - Alderfer J AU - Güler E AU - Koulias C PY - 2026 JO - American journal of clinical dermatology DO - 10.1007/s40257-026-01030-5 UR - https://doi.org/10.1007/s40257-026-01030-5 ER -
APA
G, Y., MJ, G., SB, E., G, B., RA, E., S, G., P, B., DE, M., J, A., E, G., & C, K. (2026). Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DARE.. American journal of clinical dermatology. https://doi.org/10.1007/s40257-026-01030-5
Source records
- pubmed · retrieved 2026-09-25T21:41:30.232Z